Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
This heritage has given the company experience and capabilities that also enable it to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 41,600 people in 75 countries and markets its products in more than 180 countries. The company has built its business on the conviction that the formula for lasting success is to stay focused, think long-term and do business in a financially, socially and environmentally responsible way. To this end it manages its business in accordance with the Triple Bottom Line principle.